Synergistic Cannabidiol Therapy Systems

Publication ID: 24-11857678_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Cannabidiol Therapy Systems,” Published Technical Disclosure No. 24-11857678_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857678_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,678.

Summary of the Inventive Concept

A novel approach integrating self-emulsifying cannabidiol formulations with advanced technologies such as AI, IoT, blockchain, and new materials to create personalized, real-time, and secure therapy systems.

Background and Problem Solved

The original patent disclosed self-emulsifying cannabidiol formulations, but these formulations lacked personalized treatment planning, real-time efficacy monitoring, and secure data management. The new inventive concept addresses these limitations by combining the original formulation with cutting-edge technologies.

Detailed Description of the Inventive Concept

The synergistic cannabidiol therapy system comprises a self-emulsifying cannabidiol composition, an AI-powered dosing algorithm, a blockchain-based patient data storage system, and IoT-enabled devices for real-time monitoring. The system enables personalized treatment planning, secure data management, and real-time efficacy monitoring. The AI-powered dosing algorithm optimizes treatment outcomes based on individual patient data, while the blockchain-based patient data storage system ensures secure and transparent data management. The IoT-enabled devices transmit data to a cloud-based analytics platform for analysis and feedback.

Novelty and Inventive Step

The new inventive concept introduces a synergistic combination of self-emulsifying cannabidiol formulations with AI, IoT, blockchain, and new materials, which is non-obvious and novel compared to the original patent. The integration of these technologies enables personalized, real-time, and secure therapy systems that were not possible with the original formulation alone.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include wearable devices for transdermal delivery, smart packaging systems with NFC tags, and decentralized applications for cannabidiol treatment planning. Variations of the system can be implemented using different AI algorithms, IoT devices, or blockchain platforms.

Potential Commercial Applications and Market

The synergistic cannabidiol therapy system has significant commercial potential in the healthcare and wellness industries, particularly in the areas of personalized medicine, medical cannabis, and digital health. The system's ability to provide real-time efficacy monitoring, secure data management, and personalized treatment planning makes it an attractive solution for healthcare providers, patients, and pharmaceutical companies.

CPC Classifications

SectionClassGroup
A A61 A61K9/107
A A61 A61K9/4808
A A61 A61K9/4825
A A61 A61K31/05
A A61 A61K47/10
A A61 A61K47/14
A A61 A61K47/22

Original Patent Information

Patent NumberUS 11,857,678
TitleSelf-emulsifying cannabidiol formulations
Assignee(s)Benuvia Operations, LLC